10:12 AM EST - Antibe Therapeutics Inc. : Is extending the Early Warrant Exercise Incentive Program for its 6.4 million outstanding and unlisted share purchase warrants having an exercise price of $1.50 and expiring on July 31, 2024. Antibe Therapeutics Inc.
shares T.ATE are trading unchanged at $1.01.
